We send out weekly newsletters to our members about announcements, event information, and what YGCC is reading blog. You can find our past blog below.
Please subscribe to our newsletter now to keep track of the latest content!
What YGCC is Reading #335
IBM Explores Sale of IBM Watson Health
Watson Health, powered by IBM's advanced artificial intelligence and data analytics, was one of the high-profile initiatives of the company. Despite billions of dollars of investment in its genomics and oncology projects, Watson's cancer applications and tools did not add as much value as expected and struggle to generate sustainable profit for Big Blue. The current CEO is putting more weight on cloud computing and seeking an exit strategy to let go of the unit.
Conduct secondary research and identify major challenges that Watson Health faces (e.g. physicians were hesitant to adopt artificial intelligence).
Alphabet health company Verily recently raised $700M. How can Verily better deliver value propositions and expand its market footprint?